About Ascribe Bioscience
Ascribe Bioscience is a Chemicals & Materials company based in Ithaca (United States) founded in 2017 by Murli Manohar. Microbe-based biological inputs for crop pathogen control are developed. It operates in the Chemicals & Materials and Agriculture sectors. Ascribe Bioscience has raised $17.68 million across 9 funding rounds from investors including Corteva Agriscience, HHS and The Yield Lab. Ascribe Bioscience offers products and services including Phytalix. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Biologicals. Its legal entity is ASCRIBE BIOSCIENCE INC. Its competitors include Ginkgo Bioworks, AgBiome and Pluton Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Ascribe Bioscience was founded in 2017 in Ithaca, United States, within the agricultural biotechnology sector. Microbe-based biological inputs for crops are developed, focusing on natural biopesticides. Plant immunity is enhanced, and pathogens such as fungi, bacteria, nematodes, and viruses are targeted across various crops. Applications include seed treatments, foliar sprays, and soil additives to support crop protection operations.
- Headquarters Ithaca, United States
- Founders Murli Manohar
- SectorsChemicals & MaterialsAgriculture
- Website ascribebio.com
- Social LinkedIn X
- Legal Name Ascribe Bioscience Inc.
- Total Equity Funding$17.68M (USD)
in 9 rounds
- Latest Funding Round$12M (USD), Series A
Oct 2025
- InvestorsCorteva Agriscience
& 9 more
Products & Services of Ascribe Bioscience
Ascribe Bioscience offers a comprehensive portfolio of products and services, including Phytalix.
Natural product that protects crops from fungal and bacterial pathogens using soil molecules.
Funding Insights of Ascribe Bioscience
Ascribe Bioscience has successfully raised a total of $17.68M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.68M
- Total Rounds 9
- Last Round Series A — $12M
- First Round $224,923
(Feb 2019)
- Investors Count 10
All 9 funding rounds of Ascribe Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $12M | Series A | – | Corteva Agriscience | |
| Feb 2025 | Series A | – | – | ||
| Nov 2024 | Series A | – | Source Agriculture | – | |
| Aug 2022 | $3.18M | Series A | – | – | – |
| Jul 2022 | $299,999 | Grant | – | – | |
| Nov 2021 | $2.5M | Seed | – | The Yield Lab, Acre Venture Partners | |
| Jul 2020 | $1.4M | Grant | – | – | |
| Apr 2020 | $3.02M | Grant | – | – | |
| Feb 2019 | $224,923 | Grant | – | – |
10 investors in total: 10 institutional.
Investors in Ascribe Bioscience
Ascribe Bioscience has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Corteva Agriscience, HHS and The Yield Lab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A privately owned industrial group focused on chemical investments. | ic-investors.com | Frankfurt, Germany | ||
Venture capital firm & accelerator focused on early-stage companies | 2014 | theyieldlab.com | St. Louis, United States | |
Early & late stage life sciences & tech focused VC firm investing primarily in the US | acre.vc | Santa Monica, United States | ||
Trailhead Capital is focused on regenerative agriculture investments. | trailheadcap.com | Denver, United States | ||
Early-stage tech companies are funded by this venture capital firm. | cultivationcapital.com | St. Louis, United States | ||
Invests in agricultural tech, acquires farmland, and develops renewable energy projects. | 2023 | sourceagriculture.com | Carson City, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Early-stage investments are made in food, agriculture, and oceans sectors. | ponderosavc.com | |||
Manufacturer and supplier of agricultural farm inputs | 2017 | corteva.com | Wilmington, United States | |
Investments are directed toward agri-food sectors via fund of funds. | syngentagroupventures.com | Basel, Switzerland |
Investor details for Ascribe Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ascribe Bioscience
2 people are tracked at Ascribe Bioscience (2 in leadership).
| Name | Role | Group |
|---|---|---|
Murli Manohar | Co-Founder | Leadership |
Gabriel Wilmoth | Chief Operating Officer | Leadership |
Complete people profiles for Ascribe Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ascribe Bioscience
3 dated milestones of Ascribe Bioscience across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Ascribe Bioscience is founded.
- Funding First funding round of $225K.
- Funding Latest funding round, Series A, of $12.0M.
Competitors of Ascribe Bioscience
Ascribe Bioscience has 3 listed competitors in our database, 3 of them funded. They include Ginkgo Bioworks, AgBiome and Pluton Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ginkgobioworks.com | 2008 | Boston, United States | $795.75M | 1,218 | Gene editing-based cultured ingredients are provided for agriculture. | |
| agbiome.com | 2012 | Raleigh, United States | $233M | 102 | Provider of microbe-based crop protection solutions | |
| plutonbio.com | 2017 | St. Louis, United States | $24.18M | 15 | Assay-based microbial research services are offered for industrial applications. |
Detailed competitors of Ascribe Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ascribe Bioscience
The website of Ascribe Bioscience (ascribebio.com) receives about 4.9K visits a month.
- Monthly visits4.9K
▲ 349.8% vs previous month
Websites whose visitors overlap most with Ascribe Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| futurecobioscience.com | 100% | 5.2K | #3,294,375 | View details | |
| elementalenzymes.com | 96% | 2.9K | #5,426,005 | View details | |
revistacultivar.com | revistacultivar.com | 87% | #1,401,449 | – | |
| growarber.com | 83% | 11.5K | #2,206,077 | View details | |
martinsproducesupplies.com | martinsproducesupplies.com | 83% | #3,514,517 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Ascribe Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Chemicals Tech
3 companies that operate in the same segment as Ascribe Bioscience (Chemicals Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Microbe-based plant protection products and yield optimization services are provided. | 2013 | Boston, Massachusetts, United States | USD 1.4 B | 1,316 | ||
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | |||
Sustainable bio-based chemicals are manufactured using a proprietary platform. | 2016 | Houston, Texas, United States | USD 656.05 M | 133 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ascribe Bioscience
Complete news archive for Ascribe Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ascribe Bioscience
Ascribe Bioscience was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Ascribe Bioscience is headquartered in Ithaca, United States. It is registered at Ithaca, New York, United States.
Ascribe Bioscience is a funded company, having raised a total of $17.68M across 9 funding rounds to date. The company's 1st funding round was a Grant of $224.92K, raised on Feb 2019.
Ascribe Bioscience was founded in 2017 in Ithaca, United States, within the agricultural biotechnology sector. Microbe-based biological inputs for crops are developed, focusing on natural biopesticides. Plant immunity is enhanced, and pathogens such as fungi, bacteria, nematodes, and viruses are targeted across various crops. Applications include seed treatments, foliar sprays, and soil additives to support crop protection operations.
Ascribe Bioscience's top competitors include Ginkgo Bioworks, AgBiome and Pluton Biosciences.
Ascribe Bioscience offers Phytalix.
Ascribe Bioscience has 10 investors. Key investors include Corteva Agriscience, HHS, The Yield Lab, International Chemical Investors, and Source Agriculture.
Ascribe Bioscience operates through Ascribe Bioscience Inc..